Clinical Trial Update: A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD [Phase 2]

View source ↗

Summary

This document reports the results of a Phase 2 randomized, double-blind, placebo-controlled trial evaluating PCN-101 for treatment-resistant depression; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• PCN-101

Snippet

Sponsor: Perception Neuroscience | Conditions: Treatment Resistant Depression | Phase 2 | Status: COMPLETED | Results posted: 2024-06-04